Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1988 Mar;63(3):292–296. doi: 10.1136/adc.63.3.292

Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis.

M Aricò 1, L Nespoli 1, R Maccario 1, D Montagna 1, F Bonetti 1, D Caselli 1, G R Burgio 1
PMCID: PMC1778784  PMID: 3355209

Abstract

Ten children with the characteristic clinical and haematological features of haemophagocytic lymphohistiocytosis are reported. Four patients treated with a combination of drugs comprising etoposide, methotrexate, and steroids were in complete remission after 10 to 30 months. Natural cytotoxic mechanisms including natural killer cell activity, antibody dependent cell mediated cytotoxicity, lymphokine activated killer cell activity, and natural killer cell like activity were persistently absent or severely impaired in these four patients despite their clinical remission. Their parents and one healthy sibling also had impaired natural cytotoxic mechanisms. Constitutional impairment of natural cytotoxic mechanisms could be important in the pathogenesis of haemophagocytic lymphohistiocytosis.

Full text

PDF
292

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambruso D. R., Hays T., Zwartjes W. J., Tubergen D. G., Favara B. E. Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213. Cancer. 1980 May 15;45(10):2516–2520. doi: 10.1002/1097-0142(19800515)45:10<2516::aid-cncr2820451008>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  2. Antonelli P., Stewart W., 2nd, Dupont B. Distribution of natural killer cell activity in peripheral blood, cord blood, thymus, lymph nodes, and spleen and the effect of in vitro treatment with interferon preparation. Clin Immunol Immunopathol. 1981 May;19(2):161–169. doi: 10.1016/0090-1229(81)90059-3. [DOI] [PubMed] [Google Scholar]
  3. Becton D. L., Kurtzberg J., Kinney T. R., Friedman H. S., Chaffee S., Falletta J. M. Treatment of lymphohistiocytic erythrophagocytosis with VP-16 and aziridinylbenzoquinone. Med Pediatr Oncol. 1987;15(2):58–61. doi: 10.1002/mpo.2950150203. [DOI] [PubMed] [Google Scholar]
  4. Burgio G. R., Lanzavecchia A., Maccario R., Vitiello A., Plebani A., Ugazio A. G. Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children. Clin Exp Immunol. 1978 Aug;33(2):298–301. [PMC free article] [PubMed] [Google Scholar]
  5. Devictor D., Fischer A., Mamas S., de Saint Basile G., Durandy A., Buriot D., Griscelli C. Etude immunologique de la lymphohistiocytose familiale. A propos de huit nouvelles observations. Arch Fr Pediatr. 1982 Mar;39(3):135–140. [PubMed] [Google Scholar]
  6. Dubey D. P., Yunis I., Leslie C. A., Mehta C., Yunis E. J. Homozygosity in the major histocompatibility complex region influences natural killer cell activity in man. Eur J Immunol. 1987 Jan;17(1):61–66. doi: 10.1002/eji.1830170111. [DOI] [PubMed] [Google Scholar]
  7. FARQUHAR J. W., CLAIREAUX A. E. Familial haemophagocytic reticulosis. Arch Dis Child. 1952 Dec;27(136):519–525. doi: 10.1136/adc.27.136.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fischer A., Cerf-Bensussan N., Blanche S., Le Deist F., Bremard-Oury C., Leverger G., Schaison G., Durandy A., Griscelli C. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J Pediatr. 1986 Feb;108(2):267–270. doi: 10.1016/s0022-3476(86)81002-2. [DOI] [PubMed] [Google Scholar]
  9. Fischer A., Virelizier J. L., Arenzana-Seisdedos F., Perez N., Nezelof C., Griscelli C. Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation. Pediatrics. 1985 Aug;76(2):263–268. [PubMed] [Google Scholar]
  10. Gencik A., Signer E., Müller H. Genetic analysis of familial erythrophagocytic lymphohistiocytosis. Eur J Pediatr. 1984 Sep;142(4):248–252. doi: 10.1007/BF00540245. [DOI] [PubMed] [Google Scholar]
  11. Gilbert E. F., ZuRhein G. M., Wester S. M., Herrmann J., Hong R., Opitz J. M. Familial hemophagocytic lymphohistiocytosis: report of four cases in two families and review of the literature. Pediatr Pathol. 1985;3(1):59–92. doi: 10.3109/15513818509068838. [DOI] [PubMed] [Google Scholar]
  12. Henter J. I., Elinder G., Finkel Y., Söder O. Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis. Lancet. 1986 Dec 13;2(8520):1402–1402. doi: 10.1016/s0140-6736(86)92047-7. [DOI] [PubMed] [Google Scholar]
  13. Janka G. E. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr. 1983 Jun-Jul;140(3):221–230. doi: 10.1007/BF00443367. [DOI] [PubMed] [Google Scholar]
  14. Kohl S., Frazier J. J., Greenberg S. B., Pickering L. K., Loo L. S. Interferon induction of natural killer cytotoxicity in human neonates. J Pediatr. 1981 Mar;98(3):379–384. doi: 10.1016/s0022-3476(81)80699-3. [DOI] [PubMed] [Google Scholar]
  15. Ladisch S., Ho W., Matheson D., Pilkington R., Hartman G. Immunologic and clinical effects of repeated blood exchange in familial erythrophagocytic lymphohistiocytosis. Blood. 1982 Oct;60(4):814–821. [PubMed] [Google Scholar]
  16. Ladisch S., Poplack D. G., Holiman B., Blaese R. M. Immunodeficiency in familial erythrophagocytic lymphohistiocytosis. Lancet. 1978 Mar 18;1(8064):581–583. doi: 10.1016/s0140-6736(78)91028-0. [DOI] [PubMed] [Google Scholar]
  17. Maggiore G., Scotta M. S., De Giacomo C., Siena S., Nespoli L., Ugazio A. G. Déséquilibre des sous-populations lymphocytaires chez un enfant atteint de lymphohistiocytose familiale. Arch Fr Pediatr. 1983 Feb;40(2):129–130. [PubMed] [Google Scholar]
  18. Ortaldo J. R., Herberman R. B. Heterogeneity of natural killer cells. Annu Rev Immunol. 1984;2:359–394. doi: 10.1146/annurev.iy.02.040184.002043. [DOI] [PubMed] [Google Scholar]
  19. Perez N., Virelizier J. L., Arenzana-Seisdedos F., Fischer A., Griscelli C. Impaired natural killer activity in lymphohistiocytosis syndrome. J Pediatr. 1984 Apr;104(4):569–573. doi: 10.1016/s0022-3476(84)80549-1. [DOI] [PubMed] [Google Scholar]
  20. Toivanen P., Uksila J., Leino A., Lassila O., Hirvonen T., Ruuskanen O. Development of mitogen responding T cells and natural killer cells in the human fetus. Immunol Rev. 1981;57:89–105. doi: 10.1111/j.1600-065x.1981.tb00443.x. [DOI] [PubMed] [Google Scholar]
  21. Uksila J., Lassila O., Hirvonen T. Natural killer cell function of human neonatal lymphocytes. Clin Exp Immunol. 1982 Jun;48(3):649–654. [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES